Podiatrists in Bel Aire, KS - Medicare Status, Address, Contact

1 Podiatrists found. Showing 1 - 1

Thomas Mark Haberman, DPM
Podiatrist
Medicare: Not Enrolled in Medicare
Practice Location: 4524 N Fritillary Ct, Bel Aire, KS 67226
Phone: 316-577-5038 Fax: 316-744-6404

News Archive

Older people less likely to share memories of their past experiences

By the time people reach a certain age, they've accumulated enough life experience to have plenty of stories to tell about life "back in their day."

With reform, community health centers will see federal funds double

The Wall Street Journal reports that the health overhaul bill signed by President Barack Obama will increase spending "by $10 billion over five years for [some] clinics, known as community health centers. An additional $2.5 billion is included in a package of changes to that bill, which is expected to get final approval in Congress as soon as this week."

Cedars-Sinai Medical Center honored with national consumer award

For the 17th year in a row, Cedars-Sinai Medical Center has been honored with a national consumer award for having the best overall healthcare quality, doctors and nurses in the Los Angeles area based on an independent survey of households.

Many children incorrectly restrained in cars

Car accidents are the main cause of serious injury and death among children in Norway. A new study from the Norwegian Institute of Public Health shows that 37 per cent of all children under 16 years are incorrectly restrained in the car. 23 per cent of children are so poorly restrained that a collision would have very serious consequences. The study results were presented at a seminar on traffic accidents in Oslo on 8th October.

Merrimack Pharmaceuticals commences dosing in MM-121/Tarceva combination Phase 1/2 study for NSCLC

Merrimack Pharmaceuticals, Inc. announced today that the first patient has received an initial dose in a Phase 1/2 clinical study combining MM-121 with Tarceva® (erlotinib) in patients with non-small cell lung cancer (NSCLC). This is the first of multiple trials that Merrimack and sanofi-aventis expect to initiate in 2010 as part of a broad Phase 2 clinical development program for MM-121.

Podiatrists in Bel Aire, KS Accepting Medicare